Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
14.82
-0.23 (-1.53%)
Mar 31, 2025, 10:03 AM EDT - Market open
Takeda Pharmaceutical Market Cap
Takeda Pharmaceutical has a market cap or net worth of $44.99 billion as of March 31, 2025. Its market cap has decreased by -0.58% in one year.
Market Cap
44.99B
Enterprise Value
77.90B
1-Year Change
-0.58%
Ranking
Category
Stock Price
$14.82
Market Cap Chart
Since January 5, 2010, Takeda Pharmaceutical's market cap has decreased from $71.21B to $44.99B, a decrease of -36.82%. That is a compound annual growth rate of -2.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 47.71B | 13.26% |
| Dec 31, 2024 | 42.13B | -5.91% |
| Dec 29, 2023 | 44.78B | -7.43% |
| Dec 30, 2022 | 48.37B | 13.50% |
| Dec 31, 2021 | 42.62B | -24.84% |
| Dec 31, 2020 | 56.70B | -8.18% |
| Dec 31, 2019 | 61.76B | 134.31% |
| Dec 31, 2018 | 26.36B | -59.21% |
| Dec 30, 2016 | 64.61B | -22.54% |
| Dec 31, 2015 | 83.40B | 20.68% |
| Dec 31, 2014 | 69.11B | -9.90% |
| Dec 31, 2013 | 76.71B | 3.69% |
| Dec 31, 2012 | 73.97B | 0.68% |
| Dec 30, 2011 | 73.47B | -9.45% |
| Dec 31, 2010 | 81.14B | 13.94% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |